Vivo Capital, LLC

Position in ERAS — Erasca, Inc.

CIK 1674712 Palo Alto, CA

Position in ERAS

as of Mar 31, 2026 · filed May 20, 2026 Compact

Position Value

$196,610,946

+$162,113,794 QoQ

Shares Held

12,151,480

+31.0% QoQ

Ownership

3.91%

of shares outstanding

% of Portfolio

16.88%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vivo Capital, LLC holds $1,160,013,312 across 42 Biotechnology names. ERAS ranks #1 (16.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ERAS	Erasca, Inc. This page	12,151,480	$196,610,946
2	PRAX	Praxis Precision Medicines, Inc.	338,895	$109,188,580
3	TERN	Terns Pharmaceuticals, Inc.	1,334,418	$70,350,516
4	TRVI	Trevi Therapeutics, Inc.	5,094,668	$60,779,389
5	DBVT	DBV Technologies S.A.	2,667,569	$55,725,516
6	CMPX	Compass Therapeutics, Inc.	9,545,466	$50,495,515
7	TNGX	Tango Therapeutics, Inc.	2,154,780	$45,077,997
8	SABS	SAB Biotherapeutics, Inc.	11,420,000	$43,738,600

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$196,610,946	12,151,480	+31.0%	Shares	Sole	2026-05-20
2025-12-31	$34,497,152	9,273,428	0.0%	Shares	Sole	2026-02-13
2025-09-30	$20,216,073	9,273,428	+37.2%	Shares	Sole	2025-11-14
2025-06-30	$8,581,080	6,756,756	0.0%	Shares	Sole	2025-08-14
2025-03-31	$9,256,755	6,756,756	0.0%	Shares	Sole	2025-05-12
2024-12-31	$16,959,457	6,756,756	0.0%	Shares	Sole	2025-02-13
2024-09-30	$18,445,943	6,756,756	0.0%	Shares	Sole	2024-11-13
2024-06-30	$15,945,944	6,756,756	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.